DocMorris AG (SWX: DOCM)
Switzerland
· Delayed Price · Currency is CHF 31.36
+0.56 (1.82%)
Nov 20, 2024, 4:31 PM CET
DocMorris AG Revenue
DocMorris AG had revenue of 496.28M CHF in the half year ending June 30, 2024, with 0.33% growth. This brings the company's revenue in the last twelve months to 1.00B, up 11.51% year-over-year. In the year 2023, DocMorris AG had annual revenue of 969.46M with 4.13% growth.
Revenue (ttm)
1.00B
Revenue Growth
+11.51%
P/S Ratio
0.36
Revenue / Employee
690.15K
Employees
1,453
Market Cap
396.97M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 969.46M | 38.49M | 4.13% |
| Dec 31, 2022 | 930.97M | -795.53M | -46.08% |
| Dec 31, 2021 | 1.73B | 249.57M | 16.90% |
| Dec 31, 2020 | 1.48B | 121.39M | 8.96% |
| Dec 31, 2019 | 1.36B | 148.43M | 12.30% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Roche Holding AG | 60.58B |
| Roche Holding AG | 60.58B |
| Novartis AG | 42.18B |
| Lonza Group AG | 6.70B |
| Galderma Group AG | 3.88B |
| Sonova Holding AG | 3.71B |
| Straumann Holding AG | 2.54B |
| Ypsomed Holding AG | 617.07M |